Toll-like receptor 3 (TLR3) activation plays an important role in the innate immune responses to viral infections. We show here that the activation of TLR3 signaling pathway by poly I:C, a synthetic mimic of dsRNA, could induce high-level expression of interferon (IFN)-1 in a hepatoma cell line. The induced IFN-l1 contributed to poly I:C-mediated inhibition of hepatitis C virus (HCV) Japanese fulminant hepatitis-1 (JFH-1) replication in Huh7 cells. This inhibitory effect of poly I:C on HCV replication, however, was compromised by HCV infection of Huh7 cells. Investigation of the mechanisms showed that HCV infection suppressed the expression of poly I:C-induced IFN-1 and IFN-stimulated genes [IFNstimulated gene 56 (ISG-56), myxovirus resistance A (MxA) and 2 0 -5 0 -oligoadenylate synthetase 1 (OAS-1))], the key antiviral elements in IFN signaling pathway. Among the HCV nonstructural (NS) proteins tested, NS3/4A, NS5A and NS5B had the ability to inhibit poly I:C-induced IFN-1 expression in Huh7 cells. These observations provide the experimental evidence that HCV and its proteins impair TLR3 signaling and inhibit intracellular IFN-1/ISG expression in a hepatoma cell line, which may account for HCV persistence in the liver.
Introduction
Hepatitis C virus (HCV) infection is a major cause of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. 1 The clinical outcome of HCV infection and the degree of liver damage are the result of complicated interactions between the virus and host immune responses. 2 Although cellular and humoral immune responses are present during acute and chronic HCV infection, these immune responses appear to be ineffective in eradicating the virus. 3 The majority of HCVinfected patients develop chronic infection, suggesting that HCV has evolved strategies to overcome or evade host immune responses. [4] [5] [6] [7] [8] Viral infections result in induction of interferons (IFNs) that are the key players in antiviral responses. 9 Induction of the IFN-based antiviral innate immunity depends on several Toll-like receptors (TLRs), i.e. TLR3, 7 and 9. 10 TLR3 is a major intracellular sensor that recognizes dsRNA and triggers the IFN signaling pathway. However, persistent HCV infection is associated with its ability to disrupt and evade TLR3-mediated immune responses. HCV nonstructural (NS)3/4A protease ablates TLR3 signaling by cleaving the TLR3 adaptor protein Toll-IL-1 receptor domain-containing adaptor inducing IFN-(TRIF) to evade type I IFN-mediated innate immunity. 11 Recent studies have demonstrated that, in addition to IFN-/, IFN-also has the ability to inhibit HCV replication in both in vitro and in in vivo systems. [12] [13] [14] [15] [16] [17] In the present study we examined whether TLR3 signaling induces IFN-expression and whether HCV inhibits IFN-expression in hepatoma cell line.
Materials and methods

Cells, plasmids and virus
A hepatoma cell line (Huh7) provided by Dr Charles Rice (The Rockefeller University, New York, NY, USA) was maintained in DMEM with 10% FBS, penicillin (100 U/ml) and streptomycin (100 mg/ml). HCV NS3, NS3/4A, NS5A and NS5B plasmids, and control plasmid (pcDNA 3.1) were obtained from Dr Michael Gale (University of Washington, Seattle, WA, USA). 5 The generation of infectious HCV JFH-1 and infection of Huh7 cells [multiplicity of infection (MOI) of 0.01] were carried out as described previously. 18, 19 HCV JFH-1 infection of Huh7 was analyzed by the immunostaining with the mouse anti-HCV core Ab or by real time RT-PCR for HCV RNA.
Reagents
LyoVec transfection reagent, poly I:C (high molecular mass) were purchased from Invivogen (San Diego, CA, USA). ELISA kit for IFN-1 was purchased from eBioscience Inc. (San Diego, CA, USA). Mouse Ab against HCV core antigen was purchased from ABR Affinity BioReagents, Thermo Scientific (Rockford, IL, USA). Rabbit Abs against IFN-stimulated gene 56 (ISG56), myxovirus resistance A (MxA), 2 0 -5 0 -oligoadenylate synthetase 1(OAS-1) and actin were purchased from Sigma-Aldrich (St Louis, MO, USA). Rabbit anti-IFN stimulated transcription factor 3 gamma (ISGF3G) Ab was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Hoechst 33342 was purchased from Molecular Probes (Carlsbad, CA, USA).
Poly I:C stimulation
Huh7 cells were seeded at a density of 10 5 each well in a 24 well-plate. After culturing for 24 h, the cells were stimulated with poly I:C (0.2-5 mg/ml) using LyoVec transfection reagent. Cells were collected for mRNA extraction after 24 h stimulation and supernatant (SN) was collected for ELISA assay after 24-48 h stimulation. For the anti-HCV experiment, the cells were stimulated with poly I:C for 8 h prior to HCV JFH-1 infection. Culture SN and cells were collected for mRNA extraction at JFH-1 72 h post-infection. For the poly I:C stimulation of HCV JFH-1-infected Huh7 cells experiment, JFH-1-infected Huh7 cells (72 h post-infection) were stimulated with poly I:C (0.2-5 mg/ ml) using LyoVec transfection reagent. Culture SN and cells were collected for mRNA extraction after 48 h stimulation. As a negative control of the transfection experiment, cells were incubated with the LyoVec transfection reagent only. For the blocking experiments with Bafilomycin A1, a vacuolar H + -ATPase inhibitor that inhibits the acidification of endosome, 20 Huh7 cells were treated with 100 nM of Bafilomycin A1 for 1 h prior to poly I:C stimulation.
Plasmid transfection
Transfection of the plasmid DNA was carried out with LyoVec transfection reagent, as recommended by the manufacturer. The Huh7 cells were transfected with the plasmids (HCV NS3, NS3/4A, NS5A and NS5B) using LyoVec transfection reagent at a ratio of LyoVec: plasmid 50:1 (ml:mg) at a final plasmids concentration of 0.5 mg/ml of each cell culture well. The empty vector (pcDNA 3.1) for HCV NS genes containing constructs was used as the control and included in parallel for each transfection experiment.
RNA extraction and real time RT-PCR
Total RNA from culture cells or SN was extracted with Tri-Reagent (Molecular Research Center, Cincinnati, OH, USA) as described previously. 21 Total RNA (1 mg) was subjected to RT using the RT system (Promega, Madison, WI, USA) with random primers for 1 h at 42 C. The reaction was terminated by incubating the reaction mixture at 99 C for 5 min, and the mixture was kept at 4 C. The resulting cDNA was used as a template for real time PCR quantification. Real time PCR was performed with 1/10 of the cDNA with the iQ SYBR Green Supermix (Bio-Rad Laboratories, Hercules, CA, USA) as described previously. 22 The amplified products were visualized and analyzed using the software MyiQ provided with the thermocycler (iCycler iQ real time PCR detection system; Bio-Rad Laboratories). The oligonucleotide primers were synthesized by Integrated DNA Technologies, Inc. (Coralville, IA, USA) and sequences will be available upon request. The cDNA was amplified by PCR and the products were measured using SYBR green I (Bio-Rad Laboratories). The data were normalized to GAPDH and presented as the change in induction relative to that of untreated control cells.
ELISA IFN-1 gene expression analyzed by the real time RT-PCR was evaluated by ELISA for protein expression. SN collected from poly I:C-stimulated Huh7 cultures was tested directly for IFN-1 protein levels by ELISA, which was performed according to the manufacturer's instructions.
Statistical analysis
Student's t-test was used to evaluate the significance of difference between groups, and multiple comparisons were performed by regression analysis and ANOVA. P-Values < 0.05 were considered significant. All data are presented as mean AE SD. Statistical analyses were performed with SPSS 11.5 for Windows (SPSS, Chicago, IL, USA). Statistical significance was defined as P < 0.05.
Results
TLR3 signaling induces IFN-1 expression
It is known that the activation of TLR3 can induce type I IFNs in human hepatocytes. 23 However, it is unclear whether TLR3 signaling has an effect on IFN-expression. We showed that poly I:C stimulation of Huh7 cells significantly induced the expression of IFN-1 at both mRNA ( Figure 1A ) and protein ( Figure 1B ) levels, and this effect was dose dependent. To investigate whether TLR3 activation is responsible for poly I:C-induced IFN-1 expression, Bafilomycin A1, an inhibitor of the TLR3 signaling pathway, was used to block the poly I:C action. As shown in Figure 1C , Bafilomycin A1 treatment compromised the poly I:Cinduced IFN-1 expression in Huh7 cells. To determine whether retinoic acid-inducible gene I (RIG-I) signaling is involved in poly I:C-mediated IFN-induction, we used Huh7.5 cells that have a defect in the RIG-I signaling pathway 18, 24 in the experiments. We showed that poly I:C could induce IFN-1 expression in Huh7.5 cells, which could be largely blocked by Bafilomycin A1 treatment ( Figure 1D ).
TLR3 signaling induces IFN-stimulated gene expression
ISGF3G also known as IFN regulatory factor 9 (IRF-9), plays a critical role in ISGs induction. 25 We observed that poly I:C induced ISGF3G expression in Huh7 cells at both mRNA ( Figure 2A ) and protein ( Figure 3 ) levels. We next examined the effect of poly I:C on the ISGs that have antiviral effects. As shown in Figure  2B -D, poly I:C significantly induced ISG56, MxA and OAS-1 mRNA expression in a dose-dependent manner. We also examined the protein levels of these ISGs; as shown in Figure 3 , poly I:C could increase the protein levels of ISG 56, OAS-1 and MxA, the key antiviral elements in the IFN signaling pathway. [26] [27] [28] [29] 
TLR3 signaling inhibits HCV replication
Knowing that TLR3 signaling could induce the expression of IFN-1 and the antiviral ISGs, we then examined whether TLR3 signaling of Huh7 cells can inhibit HCV replication. As shown in Figure 4A Huh7 cells and the degree of the suppression was correlated positively with the doses of poly I:C. This inhibitory effect of poly I:C on HCV could be observed before or after HCV infection (Figure 4 ). However, TLR3 signaling by poly I:C prior to HCV infection ( Figure 4A , C, E) was much more potent in HCV inhibition than that after HCV infection ( Figure 4B , D, F).
HCV suppresses IFN-1 and ISG expression
We next examined whether HCV has the ability to inhibit TLR3 activation-induced IFN-1 and ISG expression. We infected Huh7 cells with HCV JFH-1 at different doses (MOI 0.002, 0.01 and 0.05) for 72 h prior to poly I:C stimulation. We observed that the poly I:C-induced IFN-1 expression was decreased at both mRNA ( Figure 5A ) and protein ( Figure 5B Figure 5C ) and protein ( Figure 5D ) levels.
Discussion
The interaction of HCV and host immune responses is an important determinant of the outcome of HCV infection. Innate immunity is the first line of defense against viral infections. IFNs are the key players in host innate immunity, as they possess antiviral activity against a number of viruses, 9 including HCV. 30, 31 In addition to type I and type II IFNs, which have been known for decades as the antiviral cytokines, type III IFNs (IFN-) are also shown to have a strong antiviral function. 32 Although IFN-1 and IFN-2/3 exert biological activities similar to type I IFNs, they appear to have a more specialized role in innate antiviral defense. 32 IFN-exhibits antiviral action on HCV replication in both replicon and cell culture infectious virus model systems. [12] [13] [14] TLR3 plays a crucial role in the innate immunity against viral infection, as its activation induces type I IFN-based antiviral immunity. [33] [34] [35] However, little is known about whether TLR3 signaling of hepatocytes can induce IFN-expression against HCV infection/replication. We demonstrated that poly I:C could induce intracellular IFN-1 expression in Huh7 cells at both mRNA and protein levels. This induction of IFN-was associated with the decrease of HCV RNA and core protein expression in Huh7 cells activated by poly I:C. This finding is supported by a recent report that HCV could induce the expression of IFN-1 and ISGs in primary liver cultures, which limited the growth and spread of the virus. 36 Poly I:C, a synthetic analog of dsRNA to mimic viral infection, has been used widely in TLR3 signaling related studies for years. There are two commercially available poly I:Cs [high (HMM) or low molecular mass (LMM)]. Studies have shown that stimulation of cells with HMM or LMM poly I:C resulted in different cytokine profile. 37, 38 We demonstrated recently that the efficiency of TLR3 signaling of Huh7 cells by HMM poly I:C was significantly higher than that by LMM poly I:C. 39 In addition to being recognized by TLR3, poly I:C could be recognized by RIG-I or melanoma differentiation-associated protein 5 (MDA-5). To determine whether the TLR3 signaling is critical in HMM poly I:C-mediated IFN induction, we used Bafilomycin A1, an inhibitor of the TLR3 signaling pathway to block the poly I:C effect. We found that Bafilomycin A1 could largely block poly I:C-induced IFN-1 expression in Huh7 cells. Furthermore, to determine the role of RIG-I in poly I:C-mediated IFN-1 induction, we performed the experiments with Huh7.5 cells that have a defect in the RIG-I signaling pathway. 18, 24 We observed that poly I:C could induce IFN-1 expression in Huh7.5 cells, suggesting that poly I:C induces IFN-1 via a RIG-I independent mechanism. With regard to the role of MDA-5 in poly I:Cmediated action on IFN-1, our previous study 39 showed that the knock down of MDA-5 by siRNA had little effect on poly I:C-mediated IFN induction in Huh7.5 cells. Taken together, these results indicate clearly that TLR3 is the major sensor for the poly I:C action on IFN-1 induction in Huh7 cells.
In order to establish a persistent infection in the liver, HCV has evolved several strategies to evade host immune response, including inhibition of intracellular innate immunity. 40 Our previous study 22 demonstrated that HCV inhibits intracellular IFN-and IRF-7 expression in human hepatic cell lines. Others have documented that HCV NS3/4A protease is able to impair TLR3 by cleaving the TRIF adaptor protein and block RIG-I signaling by cleaving the mitochondrial antiviral signaling protein off the mitochondria to inhibit IRF-3 activation and IFN-expression. 11, 41, 42 In addition, HCV infection could impair IRF-7 translocation and IFN-synthesis in immortalized human hepatocytes. 43 In agreement with these findings, we showed that HCV replication impaired poly I:C-activated TLR3 signaling of Huh7 cells, which is evidenced by the observation that poly I:C-induced intracellular IFN-1 and ISG expression was inhibited by HCV in infected Huh7 cells.
HCV-encoded proteins, including structural proteins (E2, core) and NS proteins (NS3/4A, NS5A and NS5B), are immunosuppressive. 22, 40, [44] [45] [46] Among these HCV immunosuppressive proteins, NS3/4A has the ability to impair TLR3 and RIG-I signaling pathways and inhibits IFN-expression. 5, 11, 41, 42 In agreement with these findings, we showed that NS3/4A had an important role in HCV-mediated suppression of intracellular IFN-1 expression. In addition, HCV NS5A and NS5B were also involved in the HCV-mediated suppression of intracellular IFN-1 expression in hepatic cells. NS5B has been identified as a RNA-dependent RNA polymerase responsible for the synthesis of negative-strand HCV RNA. 47 Inhibition of NS5B has long been considered an attractive target for therapeutic intervention in HCVinfected patients. 47, 48 Our finding that there was a negative effect of NS5B on IFN--mediated host cell innate immunity in Huh7 cells further highlights the important role of NS5B in HCV-mediated evasion of host cell immunity.
Taken together, we have provided further evidence to demonstrate the ability of HCV to evade the antiviral mechanisms in the host cells. Our data indicate that HCV not only inhibits intracellular type I IFN (IFN-) expression, 22 but also suppresses TLR3 activation-induced type III IFN (IFN-1) expression in hepatoma cell line. Thus, HCV and its proteins use the complex mechanisms to target multiple steps of the TLR3/IFN signaling pathway in hepatocytes, compromising the intracellular innate immunity. Further studies are needed to understand the in vivo interplays between HCV and host cell innate immunity in the context of persistent infection in the liver.
